What it evaluates:
StoolOMX evaluates 25 bile acids and nine short-chain fatty acids, providing added information about microbial metabolism, bile-acid balance, motility, inflammation and microbiome function.

Best suited for patients with:

• Treatment-resistant or recurrent digestive symptoms

• Suspected bile-acid diarrhea

• Yellow, urgent or loose stool

• Constipation or altered motility

• Difficulty digesting fats

• Post-cholecystectomy symptoms

• Suspected low butyrate or impaired microbial metabolite production

• Complex cases in which knowing which organisms are present is not enough

An advanced functional add-on for patients who need information about what their microbiome is actually producing.

Type: Stand-alone urine test

What it evaluates:
Organic-acid patterns associated with cellular energy production, nutrient cofactors, oxidative stress, detoxification, neurotransmitter pathways and selected microbial metabolites.

Best suited for patients with:

• Fatigue

• Brain fog

• Suspected B-vitamin or nutrient needs

• Mitochondrial concerns

• Mood or concentration symptoms

• Oxidative stress

• Metabolic or detoxification concerns

What it evaluates:
Everything included in the regular GI-MAP, plus stool zonulin as a marker associated with intestinal-barrier regulation.

Best suited for patients with:

• Digestive symptoms plus suspected intestinal permeability

• Food-triggered symptoms

• Autoimmune or inflammatory presentations

• Multiple sensitivities

• Symptoms that extend beyond digestion

Important:
Zonulin should not be presented as a definitive diagnosis of “leaky gut.” It is one clinical marker that must be interpreted alongside symptoms, history and other results.

A more advanced GI-MAP option for patients with suspected barrier dysfunction.

Type : Stand-alone targeted stool profile

What it evaluates:
A narrower pathogen-focused assessment rather than a full microbiome and intestinal-health evaluation.

Best suited for patients with:

• Acute or persistent diarrhea

• Symptoms after travel, contaminated food or water

• Suspected food poisoning or gastrointestinal infection

• Sudden-onset nausea, cramping or loose stools

• A primary concern about infectious organisms rather than chronic dysbiosis

Not ideal for:
Patients wanting a complete picture of beneficial bacteria, digestive function, gut inflammation and microbiome balance.

What it evaluates:
GI-MAP uses qPCR technology to assess gastrointestinal pathogens, H. pylori, parasites, viruses, opportunistic organisms, commensal bacteria and digestive, inflammatory and immune markers.

Best suited for patients with:

• Persistent bloating, gas, diarrhea or constipation

• Unexplained digestive discomfort

• Suspected dysbiosis, parasites or H. pylori

• Recurrent infections or weakened gut immunity

• Skin concerns, brain fog or systemic symptoms suspected to involve the gut

• Chronic or complex cases requiring a broad overview